Innovating with Scott Amyx

Innovating with Scott Amyx


Interview with Dr. Sungwon Lim CEO and Co-Founder of ImpriMed

August 10, 2021

ImpriMed uses artificial intelligence on live cancer cell analytics to predict how a patient will respond to cancer therapy drugs before taking them.